Generics 152

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Meropenem manufacturers

152 products found

Filters

Filters

Filters , active

Country of origin : Russian-federation

Clear all

152 products found

meropenem

Vials, injection 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP successful, RMS: PT
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

meropenem

Solution for injection 500mg/vial, 1g/vial

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Libya , United States , Vietnam , Iraq
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

meropenem

Powder for solution for injection/infusion 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Georgia , Iraq , Serbia , Ukraine , Vietnam
Comments
Dossier availability depending on country legislation
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

meropenem

Vials, injection 500mg, 1g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Thailand
GMP approvals
PICS
Manufacturer #14397
A pharmaceutical manufacturer based in Asia that has been active in Asia and the Middle East for 40+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, and nutraceuticals. The main therapeutic area includes the cardiovascular system, CNS, and anti-infec'tives.

Manufacturer usually replies in 3 days

meropenem

Solution for injection 500mg, 1g, 2g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

meropenem

Powder for solution for injection/infusion 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Registered in
Bulgaria , Cyprus , Iraq , Italy , Malaysia , Pakistan , Portugal , Ukraine , United Arab Emirates
Available for
Licensing with supply, Distribution only
Manufacturer #8924

Manufacturer usually replies in 9 days

meropenem

Vials, injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18096
Since its establishment in the 1950s, the company has been enjoying the privilege of playing a major role as a forerunner in the East Asian pharmaceutical industry for over half a century. Based on the long-term goal, they strive for further growth and expansion. A strong alliance with the worldwide pharmaceutical companies allows the company to expand the market worldwide and cope with the challenging environment of the global pharmaceutical industry. Through active involvement in R&D activities, quality management, and overseas business, they fulfill the expectations of customers and shareholders.

Manufacturer usually replies in 5 days

meropenem

Solution for injection 0,5g, 1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Manufacturer #1274

Manufacturer usually replies in 3 days

meropenem + tazobactam

Injection 562.5 mg + 1.125 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

meropenem

Injection 250 mg, 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

meropenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #20981
The company has a mission to relieve the suffering of mankind from diseases with our innovative, effective, and safe pharmaceutical products. They have received more than 20 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award, and many more. These accomplishments demonstrate their sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.

Manufacturer usually replies in 7 days

meropenem

Vials, injection 0.5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18038
The primary mission of the company is to create new values to protect the lives and health of humankind and to improve the quality of life. They are striving to develop the world's leading new drugs through bold investments and cutting-edge research facilities.

Manufacturer usually replies in 5 days

meropenem

Solution for injection 1, 0.5g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
Manufacturer #9640
It was founded in the late 1980s. The purpose of the company is to improve the health and the lives of humankind. Committed to developing active ingredients of the highest quality through innovations in manufacturing technology. They have manufactured various finished products including anesthetic, cardiovascular, digestive, and antibiotics. Kyongbo Pharmaceutical is committed to evolving into a humanitarian corporation offering high-quality pharmaceuticals that improve the health and lives of humankind.

Manufacturer usually replies in 6 days

meropenem

Vials, injection 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18021
The company has been leading the hospital market with its medical products, is strengthening its global competitiveness by getting the outstanding pipeline for original medicine and medical supplies, and putting its passion to develop innovative new medicine through its global R&D network.

Manufacturer usually replies in 11 days

meropenem

Vials, injection 500mg, 1000mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16332
With more than a half-century of expertise, the company has established itself as a market leader in the production of generic pharmaceuticals. The items are sold on the domestic market and in countries such as Bolivia, Chile, Uruguay, Paraguay, Ecuador, Colombia, Azerbaijan, and Yemen. With a track record that includes antimicrobials, anti-inflammatories, analgesics, antihypertensives, and anti ulcerative, among many others, the company is now known as the laboratory with the largest medication reference guide on the market.

Manufacturer usually replies in 19 days

meropenem

Solution for injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

meropenem

Powder for solution for injection/infusion 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

meropenem

Powder for solution for injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Serbia , United Arab Emirates
Available for
Licensing with supply, Distribution only
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

meropenem

Powder for solution for injection/infusion 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref: Meronem®
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

meropenem

Vials, injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17289
The company offers a group of product portfolios consisting of leading molecules for the treatment of conditions like Alimentary Tract and Metabolism, Anti-infectives, Blood and Blood Forming Organs, Cardiovascular systems, Central Nervous systems, and Respiratory systems. It works in the complete development of these drugs, from clinical studies until the launch to the market. These specialties will be marketed either under their own brands or through licenses.

Manufacturer usually replies in 8 days

Want to view all 152 products? Create your free account today!

Meropenem

Meropenem is a broad-spectrum antibiotic. It is used in the treatment of a variety of bacterial infections which include meningitis, intra-abdominal infection, pneumonia, sepsis, and anthrax. It is also prescribed to treat Complicated Skin and Skin Structure Infections in both adult & Paediatric Patients 3 Months Of Age And Older Only, Complicated Intra-Abdominal Infections in adults and Paediatric Patients, for Bacterial Meningitis in Paediatric patients 3 Months Of Age or Older Only. Meropenem is sold under the brand names Merrem, Acus, and Adipen among others. Sumitomo Pharmaceuticals Company filed the first patent of Meropenem in 1983. It was approved for sales in the USA by the FDA in 1996. Due to its efficacy can safety record, it has earned a place on the WHO's List of Essential Medicines, and it classified Meropenem as critically important for human medicine.

Dosage Forms & administration

Meropenem is sold as a powder for an injectable solution in 500 mg and 1g vials. It is administered through an injection into the vein. For treating Complicated Skin and related Structure Infections, it can be prescribed as a single agent therapy caused by Staphylococcus aureus, pyogenes, agalactiae, viridans group streptococci, Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species., the usual recommended adult dose is 500 mg given through an IV every 8 hours. For Complicated Intra-abdominal Infections, the dose is set at 1 g, given every 8 hours. In the treatment of Community-Acquired Pneumonia, the dose is 500 mg given every 8 hours and the course is given for less than 5 days.

The price of Meropenem

In the USA, the consumer pays USD41 for a supply of 10 powder for injections of intravenous powder for injection of 500 mg. the cost of this medicine is significantly lower in the developing world, in India, a 1g injection cost around USD15.

How does Meropenem work?

Meropenem’s bactericidal activity results from the inhibition of cell wall synthesis. Meropenem works by penetrating the cell wall of Gram-positive and Gram-negative bacteria to reach the penicillin-binding- proteins. It has the highest affinities are toward PBPs 2, 3, and 4 of Escherichia coli and Pseudomonas aeruginosa and other similar infectious bacteria.

Finding Meropenem Manufacturers and Suppliers

The best way to find and gain access to Meropenem manufacturers and Meropenem suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Meropenem can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Meropenem to work with. You can fine-tune your search results using various filters too, letting you search for Meropenem from specific countries.